Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1162
https://www.valueinhealthjournal.com/article/S1098-3015(13)03067-2/fulltext
Title : Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03067-2&doi=10.1016/j.jval.2013.08.1162
First page : A505
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1012
Categories :
Tags :
Regions :
ViH Article Tags :